Shanghai Pharma Reportedly Under Investigation For Two Acquisitions
This article was originally published in PharmAsia News
Executive Summary
Shanghai Pharmaceuticals Holdings is under investigation for its acquisition of two other Chinese drug makers after it listed on the Hong Kong stock exchange last year, according to a source.